Literature DB >> 19320866

West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing.

Steven H Kleinman1, Joan Dunn Williams, Gene Robertson, Sally Caglioti, Robert C Williams, Randall Spizman, Larry Morgan, Peter Tomasulo, Michael P Busch.   

Abstract

BACKGROUND: In 2007, clients served by Blood Systems Laboratories used variable approaches for triggering West Nile virus (WNV) RNA individual-donation (ID) nucleic acid testing (NAT). These included two minipool (MP) NAT-reactive donations and a greater than 1:1000 rate in a 7-day interval (primary trigger), criteria based on one MP-NAT-reactive donation when there was WNV activity in overlapping and/or adjacent geographic areas (neighbor trigger), or zero MP-NAT-reactive donation (self-trigger). STUDY DESIGN AND METHODS: The Procleix WNV assay was used in either a 16-sample MP or an ID format. NAT-repeat reactivity or anti-immunoglobulin M (IgM) positivity defined true positives (TPs). TPs that were negative on 1:16 dilution testing were considered ID-NAT yield cases.
RESULTS: WNV NAT performed on 1,217,929 donations identified 162 TPs; 87 were detected by MP (rate of 0.008%) and 75 by ID (rate of 0.10%; p < 0.0001). There were 34 ID-NAT yield cases, including 4 IgM/immunoglobulin G (IgG)-negative and 9 IgM-positive/IgG-negative donations. Rates of yield cases by primary, neighbor, and self-triggering were 0.077, 0.052, and 0.004% (p = 0.0003). None of 11 ID-NAT yield cases detected by the neighbor trigger would have been detected if the primary trigger had been used.
CONCLUSIONS: Primary triggering criteria identified 21 viremic donations that would have been missed by MP testing; however, 11 other low-level viremic donations required more stringent criteria (e.g., neighbor trigger) for detection. It is reasonable to adopt more stringent ID-NAT triggers, including elimination of the rate criterion and triggering on one NAT-reactive donation for regions adjacent to centers which have already triggered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320866     DOI: 10.1111/j.1537-2995.2009.02127.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  West nile virus.

Authors:  Georg Pauli; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-07-04       Impact factor: 3.747

2.  West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety.

Authors:  Marion C Lanteri; Tzong-Hae Lee; Li Wen; Zhanna Kaidarova; Marjorie D Bravo; Nancy E Kiely; Hany T Kamel; Leslie H Tobler; Philip J Norris; Michael P Busch
Journal:  Transfusion       Date:  2014-06-26       Impact factor: 3.157

Review 3.  Progress on the development of therapeutics against West Nile virus.

Authors:  Michael S Diamond
Journal:  Antiviral Res       Date:  2009-06-06       Impact factor: 5.970

4.  West Nile virus infection incidence based on donated blood samples and neuroinvasive disease reports, Northern Texas, USA, 2012.

Authors:  Diana T Cervantes; Shande Chen; Laurie J Sutor; Shelley Stonecipher; Nicolette Janoski; David J Wright; Michael P Busch
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

5.  West Nile virus positive blood donation and subsequent entomological investigation, Austria, 2014.

Authors:  Jolanta Kolodziejek; Bernhard Seidel; Christof Jungbauer; Katharina Dimmel; Michael Kolodziejek; Ivo Rudolf; Zdenek Hubálek; Franz Allerberger; Norbert Nowotny
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

6.  Climate change projections of West Nile virus infections in Europe: implications for blood safety practices.

Authors:  Jan C Semenza; Annelise Tran; Laura Espinosa; Bertrand Sudre; Dragoslav Domanovic; Shlomit Paz
Journal:  Environ Health       Date:  2016-03-08       Impact factor: 5.984

Review 7.  Surveillance of transfusion-transmissible infections comparison of systems in five developed countries.

Authors:  Sheila F O'Brien; Shimian Zou; Syria Laperche; Lisa J Brant; Clive R Seed; Steven H Kleinman
Journal:  Transfus Med Rev       Date:  2011-09-25

8.  Current epidemiology and clinical practice in arboviral infections - implications on blood supply in South-East Asia.

Authors:  V C H Gan; Y-S Leo
Journal:  ISBT Sci Ser       Date:  2014-07-28

9.  Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010-2012.

Authors:  Edouard Betsem; Zhanna Kaidarova; Susan L Stramer; Beth Shaz; Merlyn Sayers; German LeParc; Brian Custer; Michael P Busch; Edward L Murphy
Journal:  Emerg Infect Dis       Date:  2017-02-15       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.